Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464178
Status:
TERMINATED
Last Update Posted:
2022-07-20
First Post:
2007-04-19
Brief Title:
A Phase II Study of Bevacizumab and Bortezomib in Patients With RelapsedRefractory Multiple Myeloma
Sponsor:
Hackensack Meridian Health
Organization:
Hackensack Meridian Health
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04
Start Date Type:
None
Primary Completion Date:
2009-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-19
First Submit QC Date:
April 19 2007
Study First Post Date:
2007-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-07-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-24
Last Update Post Date:
2022-07-20
Last Update Post Date Type:
ACTUAL